Neurological Disorders

Extensive research focusing on Multiple Sclerosis treatments, including studies of novel therapies and comparative effectiveness of existing medications. Multiple trials are evaluating treatments for both relapsing-remitting and primary progressive forms of MS.

  • Relapsing Multiple Sclerosis
  • Primary Progressive MS
  • Long-term Treatment Safety

Several innovative compounds being tested include fenebrutinib, ocrelizumab, and ublituximab for enhanced disease management.

Cardiovascular Research

Comprehensive studies addressing various cardiovascular conditions, from heart failure to prevention of major cardiovascular events. Research includes innovative treatments for atrial fibrillation and stroke prevention.

  • Heart Failure Management
  • Atherosclerotic Disease Prevention
  • Stroke Prevention

Trials evaluating new compounds like milvexian and finerenone for improved cardiovascular outcomes.

Respiratory Medicine

Clinical research examining new treatments for moderate to severe asthma, with a focus on improving control in patients with persistent symptoms. Studies evaluating novel therapeutic approaches for better disease management.

  • Uncontrolled Asthma
  • Novel Therapeutic Compounds
  • Symptom Management

Investigation of new compounds like Atuliflapon for enhanced asthma control.

Oncology Studies

Innovative research in breast cancer treatment, particularly focusing on hormone-receptor-positive cases. Studies evaluating targeted therapies for early-stage breast cancer.

  • ER-Positive Breast Cancer
  • Adjuvant Therapy
  • Endocrine Treatment

Clinical trials examining giredestrant as a potential new treatment option.